Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAD1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
mRNA | RP11-307N16.6 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | CELF2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
mRNA | LRCH4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | SLC43A3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | INPP5D | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
mRNA | RASGRP2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | CDT1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | GRK2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
mRNA | EPHA1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |